Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

regulated markets

• Next generation small molecule Erythropoiesis Stimulating Agents

• First generation EPO in less regulated markets (Central & South America;

Africa;

Asia;

Rest of the World)

• Darbepoietin biosimilars in less regulated markets

• Next generation biologic Erythropoiesis Stimulating Agents (ESA) in less regulated markets

 

 

 

2) G-CSF and GM-CSF

 

• 2012 Sales of Branded G-CSF Products in Regulated Markets

• 1st Generation Branded G-CSF Products in Regulated Markets

• Biosimilar 1st Generation G-CSF Products in Regulated Markets

• Next Generation Branded G-CSF Products in Regulated Markets

• Biosimilar Next Generation G-CSF Products in Regulated Markets

• 1st Generation G-CSF Products in Non-Regulated Markets: India

• 1st Generation G-CSF Products in Non-Regulated Markets: China & Taiwan

• 1st Generation G-CSF Products in Non-Regulated Markets – Korea

• 1st Generation G-CSF Products in Non-Regulated Markets – Latin America

• 1st Generation G-CSF Products in Non-Regulated Markets: Other Territories

• Next Generation G-CSF Products in Non-Regulated Markets

• 1st and Next Generation GM-CSF Products in Regulated Markets

• 1st and Next Generation GM-CSF Products in Non-Regulated Markets

 

3 ) Thrombopoiesis-Stimulating Agents (TPO; IL-11)

 

• Thrombopoietin receptor (TPO-R) activators

• Interleukin-11 (IL-11) receptor activators

• Small molecule TPO-R Agonists

• Corporate TPO/IL-1
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... These bearings are uniquely suited to prevent loss of ... of the high temperatures . , Recently, a ... design engineers at Graphite Metallizing to overcome problems with ... manufacturing operation, pans containing blocks of powder mixture are ...
(Date:7/31/2014)... 2014 CollabRx, Inc. (NASDAQ: CLRX), a ... in oncology, today announced that it will hold an ... the Company's financial results for the first quarter of ... business in the current fiscal year. , The dial-in ... August 14, 2014, at 5 p.m. EDT (2 p.m. ...
(Date:7/31/2014)... Francisco, Calif. (PRWEB) July 31, 2014 ... newly diagnosed patients with an overview of the disease ... management of drug side effects, as well as updates ... “We’re grateful to Dr. Sandy Srinivas for organizing this ... survivor of kidney cancer. “Sandy and her colleagues have ...
(Date:7/31/2014)... “Rapid technological advances will spread ... increasing unemployment, depressing American consumer spending and further ... Catch 22—we need automated manufacturing if we are ... says economist and corporate relocation expert Dr. Ron ... Pro-Business States for 2014, co-published with the American ...
Breaking Biology Technology:Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4
... , ... /PRNewswire-Asia-FirstCall/ --,China Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN; ... and,retailer of pharmaceuticals in Northeastern China, today announced it ... Drug List. , The Chinese ...
... , SEATTLE, Nov. 30 ... announced today that its new class of platinum-based anti-tumor ... activity compared to currently available platinum-based compounds as well ... lines. The results were presented in a paper ...
... ... Elsevier, the world,s,leading publisher of scientific, medical and technical products and services,today ... million indexed records from more than 7,000,active, peer reviewed journals. , ... new biomedical,and pharmaceutical insights. Now, new developments and updates include: , , ...
Cached Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3
(Date:7/31/2014)... lurks beneath many of the roughly 156,000 gas ... is corrosion in parts of underground gas storage ... contamination of groundwater, a source of drinking water. ... have reported many rapidly corroding gas storage tank ... generally associated with use of gasoline-ethanol blends and ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
(Date:7/31/2014)... been made to help better identify and treat those with ... and enlarging of medium sized arteries in the body, which ... causing damage. In a new report appearing in August 2014 ... provide evidence that that FMD may not be limited to ... connection to abnormalities of bones and joints, as well as ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2C. difficile vaccine proves safe, 100 percent effective in animal models 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... 25-year non-stop research expeditioninto the deep ocean. Over the ... are completing the installation off the British Columbia coast of ... observatory. Using three ships and at least one ROV, ... 400 instruments and sensors to the seafloor where they are ...
... Van Andel Research Institute (VARI) investigators ... therapeutic target in the treatment of the most aggressive ... have few treatment options. "Breast cancer mortality rates ... to traditional treatments tend to be more aggressive and ...
... For the first time, an international group of researchers ... of DNA on chromosome 6. This is the ... The LSUHSC research team was led by Nancy Buccola, APRN, ... Sciences Center New Orleans, who also coordinated the ten clinical ...
Cached Biology News:World's largest ocean observatory takes shape 2World's largest ocean observatory takes shape 3Possible drug target found for one of the most aggressive breast cancers 2LSUHSC research helps link schizophrenia to specific DNA region 2
...
Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
... Bio-Beads SM-2 adsorbents are macroporous polystyrene beads ... high surface area for adsorbing organics of ... solutions. The beads are useful for the ... agents; for example, the removal of detergents ...
... Anti-Mi-2 Immunogen : Fusion ... residues 474-970 of human Mi-2 ... 0.105M NaCl, 0.035% sodium azide, ... routinely evaluated by immunoblot on ...
Biology Products: